Walgreens Boots Alliance Inc (NASDAQ:WBA) – Analysts at SunTrust Banks cut their Q1 2021 earnings estimates for shares of Walgreens Boots Alliance in a research report issued on Thursday, July 9th. SunTrust Banks analyst D. Macdonald now expects that the pharmacy operator will post earnings of $1.30 per share for the quarter, down from their prior forecast of $1.35. SunTrust Banks has a “Hold” rating and a $40.00 price objective on the stock. SunTrust Banks also issued estimates for Walgreens Boots Alliance’s Q2 2021 earnings at $1.49 EPS, Q3 2021 earnings at $1.43 EPS, Q4 2021 earnings at $1.38 EPS and FY2021 earnings at $5.60 EPS.

Several other research firms have also issued reports on WBA. JPMorgan Chase & Co. dropped their price target on shares of Walgreens Boots Alliance from $62.00 to $56.00 and set a “neutral” rating for the company in a research report on Friday, April 3rd. Wells Fargo & Co reissued a “hold” rating on shares of Walgreens Boots Alliance in a research report on Thursday, April 2nd. Citigroup decreased their price objective on shares of Walgreens Boots Alliance from $48.00 to $43.00 and set a “neutral” rating on the stock in a research note on Friday. UBS Group raised shares of Walgreens Boots Alliance from a “sell” rating to a “neutral” rating and decreased their price objective for the stock from $49.00 to $44.00 in a research note on Monday, April 6th. Finally, ValuEngine cut shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research note on Wednesday, May 27th. Three equities research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company. The stock has an average rating of “Hold” and a consensus target price of $46.64.

Shares of WBA opened at $39.58 on Monday. The company has a 50-day simple moving average of $42.38 and a 200-day simple moving average of $46.86. The firm has a market capitalization of $34.77 billion, a P/E ratio of 48.27, a P/E/G ratio of 2.71 and a beta of 0.55. The company has a debt-to-equity ratio of 1.60, a quick ratio of 0.33 and a current ratio of 0.69. Walgreens Boots Alliance has a 52 week low of $36.65 and a 52 week high of $64.50.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, July 9th. The pharmacy operator reported $0.83 EPS for the quarter, missing the Zacks’ consensus estimate of $1.10 by ($0.27). The company had revenue of $34.63 billion for the quarter, compared to analyst estimates of $34.32 billion. Walgreens Boots Alliance had a net margin of 0.55% and a return on equity of 19.43%. The firm’s quarterly revenue was up .1% on a year-over-year basis. During the same period in the prior year, the company posted $1.47 EPS.

Institutional investors have recently made changes to their positions in the stock. Private Ocean LLC bought a new stake in shares of Walgreens Boots Alliance during the 1st quarter valued at approximately $25,000. Americana Partners LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter worth approximately $29,000. Balentine LLC bought a new stake in Walgreens Boots Alliance during the 1st quarter worth approximately $29,000. Pearl River Capital LLC bought a new stake in Walgreens Boots Alliance during the 1st quarter worth approximately $35,000. Finally, Perennial Advisors LLC bought a new stake in Walgreens Boots Alliance during the 1st quarter worth approximately $36,000. 57.12% of the stock is currently owned by institutional investors.

The business also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Wednesday, August 19th will be issued a dividend of $0.4675 per share. The ex-dividend date is Tuesday, August 18th. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.46. This represents a $1.87 annualized dividend and a dividend yield of 4.72%. Walgreens Boots Alliance’s payout ratio is 30.55%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Recommended Story: How is diluted EPS different from basic EPS?

Earnings History and Estimates for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.